Research Article
BibTex RIS Cite

Clinical Presentation and Treatment of Systemic Lupus Erythematosus in Childhood:Single Center Experience

Year 2020, Volume: 14 Issue: 3, 225 - 230, 29.05.2020
https://doi.org/10.12956/tchd.565251

Abstract

Objective: Systemic lupus erythematosus (SLE) is a chronic connective tissue disease caused by autoimmune,

immunological disorders which can effect many organs and systems. The aim of this study was to evaluate the

complaints, clinical and laboratory findings of patients with SLE.

Material and Methods: This study was performed between January 2001 and January 2014 by the Department of

Child Nephrology-Rheumatology with the diagnosis of SLE. In this study, clinical and laboratory findings, treatment,

organ involvement of the patients, who were followed up with the diagnosis of SLE, were recorded.

Results: Thirteen patients (10 girls, 3 boys) who received 4 or more of 11 SLE criteria renewed in 1997 by the American

College of Rheumatology (ACR) or who had consistent findings with lupus nephritis by kidney biopsy were included in

the study. There were 10 female (76.9%), 3 male (23.1%). Female / male ratio was 3.3 and mean age of 12.8 ± 2.79

(6-17 years). The mean follow-up period was 8.1 ± 2.34 years (4-13 years).

At the time of admission, 6 of the patients had rash (46.1%), 4 had edema in the legs (30.7%), 2 had swelling and pain in the joints (15.3%), 1 had chest and joint pain (7.6%) and 1 had pallor complaint (7.6%). In follow-up, 2 patients had skin, 3 had hematological, 5 had joint, 1 had serositis / pericardial and 1 patient had neurological disease






involvement. The rate of renal involvement was 84.6%. Three patients had high creatinine levels at admission and 5 patients had nephrotic


proteinuria. No correlation was found between proteinuria and creatinine at presentation and histopathological examination.


Conclusion: In this study, SLE, which started in childhood, had more than one system and organ kept at the time of diagnosis. It should


be kept in mind that SLE may present with different clinical and laboratory findings in childhood, as morbidity and mortality can be reduced


by appropriate diagnosis and treatment.

References

  • 1. Ravelli A,Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, et al. Arthritis Rheum 2003;15:501-7.
  • 2. Lehman TJ. Systemic lupusery thematosus in children and adolescents. In: Dubois’ Systemic Lupus Erythematosus, 5th ed, Wallace DA, Hahn B (Eds), WB Saunders, Philadelphia 1996.
  • 3. Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:577.
  • 4. Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun Rev 2012;12:97-106.
  • 5. Vangelista A, Stipo L, Canova C, Frascà GM, Iannelli S, Nanni- Costa A, Bonomini V. 1996. Lupus nephritis: the value of biochemical and immunological monitoring of disease activity. Ren Fail 1996;18:755-63.
  • 6. Textbook of Pediatric Rheumatology 7th edition, sectionthree, systemic connectivet issue diseases 2016;285-448.5
  • 7. Garin EH, Donnelly WH, Shulman ST, Fernandez R, Finton C, Williams RL, et al. The significance of serial measurements of serum complement C3 and C4 componentsand DNA binding capacity in patients with lupus nephritis. Clin Nephrol 1979;12:148-55.
  • 8. Schmugge M, Revel-Vilk S, Hiraki L, Rand ML,Blanchette VS, Silverman ED. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus.J Pediatr 2003;143:666- 9.
  • 9. Lehman TJ. Systemic lupusery thematosus in children and adolescents. In: Dubois’ Systemic Lupus Erythematosus, 5th ed, Wallace DA, Hahn B (Eds), WB Saunders, Philadelphia 1996.

Çocukluk Çağı Sistemik Lupus Eritematozusunda Başlangıç Bulguları ve Tedavi:Tek Merkez Deneyimi

Year 2020, Volume: 14 Issue: 3, 225 - 230, 29.05.2020
https://doi.org/10.12956/tchd.565251

Abstract

Amaç: Sistemik lupus eritematozus (SLE), immünolojik bozuklukların yol açtığı, otoimmün karakterli, birçok organ


ve sistemi tutan, kronik bir bağ dokusu hastalığıdır. Çalışmada SLE tanısı ile izlenen hastaların hastaneye başvuru


yakınmalarının, klinik ve laboratuar bulgularının değerlendirilmesi amaçlanmıştır.


Gereç ve Yöntemler: Bu çalışma Ocak 2001- Ocak 2014 tarihleri arasında Çocuk Nefroloji-Romatoloji Bölümü


tarafından SLE tanısı ile izlenen hastaların dosyaları ve bilgisayar kayıtları geriye dönük incelenerek yapılmıştır. Çalışmada


SLE tanısı ile izlenen hastaların başvuru yakınmaları, klinik ve laboratuar bulguları ile tedavileri ve izlem süresince gelişen


organ tutulumları kaydedilmiştir.


Bulgular: Çalışmaya Amerikan Romatoloji Birliği’nin (ACR) 1997 yılında yenilediği 11 SLE kriterinden 4 veya daha


fazlasını karşılayan ya da böbrek biyopsisi sonucu lupus nefriti ile uyumlu bulgular saptanan 13 hasta (10’u kız, 3’ü


erkek) alınmıştır. Hastaların 10’u kız (% 76.9), 3’ü erkek (% 23.1), kız/erkek oranı 3.3 genel yaş ortalaması 12.8±2.79


(6-17 yıl) bulundu. Hastaların ortalama izlem süresi 8.1±2.34 yıl (4-13 yıl)’dı.


Hastaneye başvuru anında hastaların 6’sında (%46.1) yüzde döküntü, 4’ünde (%30.7) bacaklarda ödem, 2’sinde (%15.3)


eklemlerde şişlik ve ağrı, 1’inde (%7.6) göğüs ve eklem ağrısı, 1’inde (%7.6) solukluk şikayeti mevcuttu.


İzlemde, 2 hastada cilt, 3 hastada hematolojik, 5 hastada eklem, 1 hastada serozit/perikard tutulumu, 1 hastada nörolojik


tutulum gelişti. Böbrek tutulum oranı % 84.6 olarak bulundu. 3 hastada başvuru anında kreatinin değeri yüksekliği ve 5


hastada nefrotik düzeyde proteinüri saptandı. Başvuru anındaki proteinüri ve kreatinin ile histopatolojik inceleme sonucu


arasında ilişki saptanmadı.


Sonuç: Bu çalışma ile çocukluk çağında başlayan SLE’de tanı anında birden fazla sistem ve organın tutulduğu, bu


nedenle başvuru şikayetinin anemiden böbrek yetmezliğine kadar değişkenlik gösterebildiği görülmüştür. Uygun tanı


ve tedavi ile morbidite ve mortalite azaltılabileceği için çocukluk çağında SLE’nin farklı klinik ve laboratuvar bulgularıyla


karşımıza gelebileceği akılda tutulmalıdır.

References

  • 1. Ravelli A,Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, et al. Arthritis Rheum 2003;15:501-7.
  • 2. Lehman TJ. Systemic lupusery thematosus in children and adolescents. In: Dubois’ Systemic Lupus Erythematosus, 5th ed, Wallace DA, Hahn B (Eds), WB Saunders, Philadelphia 1996.
  • 3. Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 2004;16:577.
  • 4. Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun Rev 2012;12:97-106.
  • 5. Vangelista A, Stipo L, Canova C, Frascà GM, Iannelli S, Nanni- Costa A, Bonomini V. 1996. Lupus nephritis: the value of biochemical and immunological monitoring of disease activity. Ren Fail 1996;18:755-63.
  • 6. Textbook of Pediatric Rheumatology 7th edition, sectionthree, systemic connectivet issue diseases 2016;285-448.5
  • 7. Garin EH, Donnelly WH, Shulman ST, Fernandez R, Finton C, Williams RL, et al. The significance of serial measurements of serum complement C3 and C4 componentsand DNA binding capacity in patients with lupus nephritis. Clin Nephrol 1979;12:148-55.
  • 8. Schmugge M, Revel-Vilk S, Hiraki L, Rand ML,Blanchette VS, Silverman ED. Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus.J Pediatr 2003;143:666- 9.
  • 9. Lehman TJ. Systemic lupusery thematosus in children and adolescents. In: Dubois’ Systemic Lupus Erythematosus, 5th ed, Wallace DA, Hahn B (Eds), WB Saunders, Philadelphia 1996.
There are 9 citations in total.

Details

Primary Language Turkish
Subjects ​Internal Diseases
Journal Section ORIGINAL ARTICLES
Authors

Semih Sandal This is me

Publication Date May 29, 2020
Submission Date October 30, 2018
Published in Issue Year 2020 Volume: 14 Issue: 3

Cite

Vancouver Sandal S. Çocukluk Çağı Sistemik Lupus Eritematozusunda Başlangıç Bulguları ve Tedavi:Tek Merkez Deneyimi. Türkiye Çocuk Hast Derg. 2020;14(3):225-30.


The publication language of Turkish Journal of Pediatric Disease is English.


Manuscripts submitted to the Turkish Journal of Pediatric Disease will go through a double-blind peer-review process. Each submission will be reviewed by at least two external, independent peer reviewers who are experts in the field, in order to ensure an unbiased evaluation process. The editorial board will invite an external and independent editor to manage the evaluation processes of manuscripts submitted by editors or by the editorial board members of the journal. The Editor in Chief is the final authority in the decision-making process for all submissions. Articles accepted for publication in the Turkish Journal of Pediatrics are put in the order of publication, with at least 10 original articles in each issue, taking into account the acceptance dates. If the articles sent to the reviewers for evaluation are assessed as a senior for publication by the reviewers, the section editor and the editor considering all aspects (originality, high scientific quality and citation potential), it receives publication priority in addition to the articles assigned for the next issue.


The aim of the Turkish Journal of Pediatrics is to publish high-quality original research articles that will contribute to the international literature in the field of general pediatric health and diseases and its sub-branches. It also publishes editorial opinions, letters to the editor, reviews, case reports, book reviews, comments on previously published articles, meeting and conference proceedings, announcements, and biography. In addition to the field of child health and diseases, the journal also includes articles prepared in fields such as surgery, dentistry, public health, nutrition and dietetics, social services, human genetics, basic sciences, psychology, psychiatry, educational sciences, sociology and nursing, provided that they are related to this field. can be published.